Free Trial
NASDAQ:TLIS

Talis Biomedical 11/14/2023 Earnings Report

Talis Biomedical logo
$1.50 0.00 (0.00%)
As of 05/27/2025

Talis Biomedical EPS Results

Actual EPS
-$8.62
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Talis Biomedical Revenue Results

Actual Revenue
$0.14 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Talis Biomedical Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Conference Call Resources

Talis Biomedical Earnings Headlines

Talis Biomedical Corp Ordinary Shares
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Talis Biomedical Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Talis Biomedical? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Talis Biomedical and other key companies, straight to your email.

About Talis Biomedical

Talis Biomedical (NASDAQ:TLIS) operates as a molecular diagnostic company, focusing on developing medical devices for infectious diseases and other conditions at the point of care in the United States. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Chicago, Illinois.

View Talis Biomedical Profile

More Earnings Resources from MarketBeat